Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Yang Liu, Fan Peng, Siyuan Wang, Huanmin Jiao, Kaixiang Zhou, Wenjie Guo, Shanshan Guo, Miao Dang, Huanqin Zhang, Weizheng Zhou, Xu Guo, Jinliang Xing

Clin Mol Hepatol. 2025;31(1):196-212. Published online October 15, 2024

DOI: https://doi.org/10.3350/cmh.2024.0527

View: 2037 Download: 194 Web of Science: 4 Crossref: 2

Letter to the Editor

Insights on risk score development: Considerations for early-stage hepatocellular carcinoma models

Zhanna Zhang, Gongqiang Wu

Clin Mol Hepatol. 2025;31(1):e8-e9. Published online November 6, 2024

DOI: https://doi.org/10.3350/cmh.2024.0958

View: 1076 Download: 42 Web of Science: 1 Crossref: 1

Comparison of the therapeutic effects of transarterial radioembolization and tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis

Hang Li, Hua Lu, Xi-Ping Shen, Xiao-Song Li

Clin Mol Hepatol. 2025;31(1):e3-e4. Published online October 7, 2024

DOI: https://doi.org/10.3350/cmh.2024.0832

View: 1216 Download: 52 Crossref: 1

Review

Roles of X-box binding protein 1 in liver pathogenesis

Jihoon Tak, Yun Seok Kim, Sang Geon Kim

Clin Mol Hepatol. 2025;31(1):1-31. Published online October 2, 2024

DOI: https://doi.org/10.3350/cmh.2024.0441

View: 2979 Download: 188 Web of Science: 1 Crossref: 1

Original Article

Assessment of the postoperative prognosis in patients with hepatocellular carcinoma using vibration-controlled transient elastography: A systemic review and meta-analysis

Jung Hwan Yu, Ji Won Han, Young Ju Suh, Young Eun Chon, Hee Yeon Kim, Ji Hyun An, Young-Joo Jin, Miyoung Choi, Seung Up Kim, Dae Won Jun, Han Ah Lee, Mi Na Kim

Clin Mol Hepatol. 2024;30(Suppl):S186-S198. Published online August 21, 2024

DOI: https://doi.org/10.3350/cmh.2024.0366

View: 2086 Download: 95 Crossref: 1

Non-invasive prediction of post-sustained virological response hepatocellular carcinoma in hepatitis C virus: A systematic review and meta-analysis

Han Ah Lee, Mi Na Kim, Hye Ah Lee, Miyoung Choi, Jung Hwan Yu, Young-Joo Jin, Hee Yeon Kim, Ji Won Han, Seung Up Kim, Jihyun An, Young Eun Chon

Clin Mol Hepatol. 2024;30(Suppl):S172-S185. Published online August 12, 2024

DOI: https://doi.org/10.3350/cmh.2024.0262

View: 2666 Download: 150 Web of Science: 1 Crossref: 3

Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis

Young-Joo Jin, Hee Yeon Kim, Young Ju Suh, Chae Hyeon Lee, Jung Hwan Yu, Mi Na Kim, Ji Won Han, Han Ah Lee, Jihyun An, Young Eun Chon, Dae Won Jun, Miyoung Choi, Seung Up Kim

Clin Mol Hepatol. 2024;30(Suppl):S159-S171. Published online July 23, 2024

DOI: https://doi.org/10.3350/cmh.2024.0163

View: 2490 Download: 129 Web of Science: 7 Crossref: 6

Reply to Correspondence

Reply to correspondence on “Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients”

Beom Kyung Kim

Clin Mol Hepatol. 2024;30(4):1044-1046. Published online July 29, 2024

DOI: https://doi.org/10.3350/cmh.2024.0584

View: 1428 Download: 30 Web of Science: 1 Crossref: 1

Reply to correspondence on “Severity of microvascular invasion does matter in hepatocellular carcinoma prognosis”

Abdelrahman M Attia, Hasmik Adetyan, Ju Dong Yang

Clin Mol Hepatol. 2024;30(4):1042-1043. Published online August 27, 2024

DOI: https://doi.org/10.3350/cmh.2024.0685

View: 1551 Download: 32 Web of Science: 1 Crossref: 3

Reply to correspondence on “Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets”

Mohammad Saeid Rezaee-Zavareh, Naomy Kim, Ju Dong Yang

Clin Mol Hepatol. 2024;30(4):1037-1038. Published online May 2, 2024

DOI: https://doi.org/10.3350/cmh.2024.0320

View: 1840 Download: 56

Correspondence

Correspondence to editorial on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”

Chun-Ting Ho, Elise Chia-Hui Tan, Chien-Wei Su

Clin Mol Hepatol. 2024;30(4):1016-1018. Published online May 20, 2024

DOI: https://doi.org/10.3350/cmh.2024.0365

View: 1780 Download: 41 Web of Science: 1 Crossref: 1

Correspondence to editorial on “Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma”

Su Bin Lim, Hyo Jung Cho

Clin Mol Hepatol. 2024;30(4):1009-1011. Published online May 20, 2024

DOI: https://doi.org/10.3350/cmh.2024.0368

View: 1821 Download: 76 Crossref: 1

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next

Viewed By 12265	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7278	Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target
Viewed By 6945	MAFLD: How is it different from NAFLD?
Viewed By 5591	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 5377	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment

Cited By 366	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 348	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 232	MAFLD: How is it different from NAFLD?
Cited By 122	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 116	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search